Sana Biotechnology
SANA
SANA
120 hedge funds and large institutions have $507M invested in Sana Biotechnology in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 41 increasing their positions, 33 reducing their positions, and 17 closing their positions.
Holders
120
Holders Change
-5
Holders Change %
-4%
% of All Funds
1.94%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
41
Reduced
33
Closed
17
Calls
$8K
Puts
$27K
Net Calls
-$19K
Net Calls Change
-$8K
Top Buyers
1 |
1
BlackRock
New York
|
$30.8M |
2 |
2
T. Rowe Price Associates
Baltimore,
Maryland
|
$16.8M |
3 |
3
Goldman Sachs
New York
|
$7.36M |
4 |
4
Nuveen Asset Management
Chicago,
Illinois
|
$2.86M |
5 |
5
UBS Group
Zurich,
Switzerland
|
$1.35M |